Posted on Wednesday, January 18th, 2006 at 5:08 pm
The effort to bring systems into regulatory compliance is complex and costly. According to industry estimates, the average large pharmaceutical company will spend
between $150 million to $250 million on regulatory compliance. An important aspect of compliance is system validation, which means that all pharmaceutical IT systems must be configured and documented (on an ongoing basis if changes are made) in accordance with regulatory guidelines.
How do pharmaceutical companies provide a cost-effective IT infrastructure that can support and safeguard the collaboration of physicians, researchers, scientists and other partners around the globe? How do they identify and respond to change while maintaining compliance? How can they leverage IT to embrace change and differentiate themselves
from competition?
